Skip to main content
logo
Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
22.90
+0.16 (0.70%)
At close: Apr 8, 2026, 4:00 PM EDT
22.90
0.00 (0.00%)
After-hours: Apr 8, 2026, 8:00 PM EDT

Pelthos Therapeutics Revenue

In the year 2025, Pelthos Therapeutics had annual revenue of $16.80M. Pelthos Therapeutics had revenue of $9.39M in the quarter ending December 31, 2025.

Revenue (ttm)
$16.80M
Revenue Growth
n/a
P/S Ratio
4.54
Revenue / Employee
$182,554
Employees
92
Market Cap
76.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202516.80M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortress Biotech63.26M
Gossamer Bio48.47M
NRx Pharmaceuticals1.23M
iBio, Inc.300.00K
aTyr Pharma190.00K
Impact BioMedical32.00K
Revenue Rankings

PTHS News

More News